Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis

被引:0
|
作者
Mosche Pompsch
Neslinur Fisenkci
Peter A. Horn
Markus Kraemer
Monika Lindemann
机构
[1] Alfried Krupp Hospital,Department of Neurology
[2] University of Duisburg-Essen,Institute for Transfusion Medicine, University Hospital Essen
[3] Medical Faculty of Heinrich-Heine-University,Department of Neurology
关键词
Ocrelizumab; B-cell depleted patients; SARS-CoV2 vaccination; Comirnaty®; T-cell mediated response; Lack of antibody response; Multiple sclerosis; COVID-19;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Humoral immune response to SARS-CoV-2 booster vaccination in patients with multiple sclerosis and healthy controls
    Krajnc, N.
    Riedl, K.
    Hegen, H.
    Traxler, G.
    Leutmezer, F.
    Di Pauli, F.
    Kornek, B.
    Rommer, P.
    Zulehner, G.
    Duerauer, S.
    Bauer, A.
    Kratzwald, S.
    Winklehner, M.
    Deisenhammer, F.
    Guger, M.
    Hoeftberger, R.
    Berger, T.
    Bsteh, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 793 - 793
  • [22] Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab
    Tolf, Andreas
    Wiberg, Anna
    Muller, Malin
    Nazir, Faisal Hayat
    Pavlovic, Ivan
    Lauren, Ida
    Mangsbo, Sara
    Burman, Joachim
    JAMA NETWORK OPEN, 2022, 5 (05) : E2211497
  • [23] Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses
    Novak, Frederik
    Bajwa, Hamza Mahmood
    Coia, John Eugenio
    Nilsson, Anna Christine
    Nielsen, Christian
    Holm, Dorte K.
    ostergaard, Kamilla
    Hvidt, Mathilde Vilhelmine Miller
    Byg, Keld-Erik
    Johansen, Isik S.
    Mittl, Kristen
    Rowles, William
    Zamvil, Scott S.
    Bove, Riley
    Sabatino, Joseph J.
    Sejbaek, Tobias
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (11): : 934 - 937
  • [24] Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'
    Westhoff, Timm H.
    Seibert, Felix S.
    Anft, Moritz
    Blazquez-Navarro, Arturo
    Skrzypczyk, Sarah
    Doevelaar, Adrian
    Hoelzer, Bodo
    Paniskaki, Krystallenia
    Dolff, Sebastian
    Wilde, Benjamin
    Witzke, Oliver
    Braun, Juergen
    Stervbo, Ulrik
    Babel, Nina
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (10)
  • [25] Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod
    Cabeza, Virginia Palomares
    Kummer, Laura Y. L.
    Wieske, Luuk
    Hagen, Ruth R.
    Duurland, Mariel
    Konijn, Veronique A. L.
    van Dam, Koos P. J.
    Stalman, Eileen W.
    van de Sandt, Carolien E.
    Boekel, Laura
    Verstegen, Niels J. M.
    Steenhuis, Maurice
    Rispens, Theo
    Tas, Sander W.
    Wolbink, Gertjan
    Killestein, Joep
    Kuijpers, Taco W.
    van Ham, S. Marieke
    Eftimov, Filip
    ten Brinke, Anja
    van Kempen, Zoe L. E.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2022, 9 (04):
  • [26] Vaccination against SARS-CoV-2 in patients with multiple sclerosis
    Costa-Frossard, Lucienne
    Garcia-Dominguez, Jose M.
    Moreno-Torres, Irene
    Fortun, Jesus
    Villar, Luisa M.
    Meca-Lallana, Virginia
    REVISTA DE NEUROLOGIA, 2021, 72 (07) : 250 - 260
  • [27] Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
    Woopen, Christina
    Schleussner, Katharina
    Akgun, Katja
    Ziemssen, Tjalf
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [28] Immune Response after SARS-CoV-2 Vaccination in Kidney Transplant Patients
    Vaiciuniene, Ruta
    Sitkauskiene, Brigita
    Bumblyte, Inga Arune
    Dalinkeviciene, Egle
    Ziginskiene, Edita
    Bagdonas, Dovydas
    Augliene, Ruta
    Petruliene, Kristina
    Bagdziuniene, Irmante
    Skarupskiene, Inga
    Stankuviene, Asta
    Sauseriene, Jolanta
    Macinskas, Sarunas
    Valius, Leonas
    MEDICINA-LITHUANIA, 2021, 57 (12):
  • [29] Humoral immune response to SARS-CoV-2 vaccination in MS patients treated with rituximab
    Torgauten, H. M.
    Cox, R. J.
    Myhr, K. -M.
    Langeland, N.
    Onyango, T. B.
    Torkildsen, O.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 775 - 775
  • [30] Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
    Allman, M.
    Tallantyre, E.
    Robertson, N. P.
    JOURNAL OF NEUROLOGY, 2022, 269 (04) : 2259 - 2261